Krüppel-like factor 4 represses transcription of the survivin gene in esophageal cancer cell lines

Biological Chemistry

Volumn 390, Issue 5-6, 2009, Pages 463-469

  Zhang, Guo ^a,b   Zhu, Hongxia ^a   Wang, Yihua ^a   Yang, Shangbin ^a   Liu, Mei ^a   Zhang, Wei ^a   Quan, Lanping ^a   Bai, Jinfeng ^a   Liu, Zhihua ^a   Xu, Ningzhi ^a  

^a CANCER HOSPITAL   (China)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Kr ppel like factor 4; Survivin; Transcription repression

Indexed keywords

KRUPPEL LIKE FACTOR 4; MESSENGER RNA; SURVIVIN;

APOPTOSIS; ARTICLE; BINDING COMPETITION; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ESOPHAGUS CANCER; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SURVIVIN GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC;

EID: 67649601502     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.060     Document Type: Article

References (31)

1. Ai, W., Liu, Y., Langlois, M., and Wang, T.C. (2004). Kruppel-like factor 4 (KLF4) represses histidine decarboxylase gene expression through an upstream Sp1 site and downstream gastrin responsive elements. J. Biol. Chem. 279, 8684-8693.
2. Altieri, D.C. (2003). Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3, 46-54.
3. Altieri, D.C. (2008). Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 8, 61-70.
4. Bao, R., Connolly, D.C., Murphy, M., Green, J., Weinstein, J.K., Pisarcik, D.A., and Hamilton, T.C. (2002). Activation of cancer-specific gene expression by the survivin promoter. J. Natl. Cancer Inst. 94, 522-528.
5. Foster, K.W., Liu, Z., Nail, C.D., Li, X., Fitzgerald, T.J., Bailey, S.K., Frost, A.R., Louro, I.D., Townes, T.M., Paterson, A.J., et al. (2005). Induction of KLF4 in basal keratinocytes blocks the proliferation- differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24, 1491-1500.
6. Garrett-Sinha, L.A., Eberspaecher, H., Seldin, M.F., and de Crombrugghe, B. (1996). A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J. Biol. Chem. 271, 31384-31390.
7. Ghaleb, A.M., Nandan, M.O., Chanchevalap, S., Dalton, W.B., Hisamuddin, I.M., and Yang, V.W. (2005). Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 15, 92-96.
8. Ghaleb, A.M., Katz, J.P., Kaestner, K.H., Du, J.X., and Yang, V.W. (2007). Kürppel-like factor 4 exhibits antiapoptotic activity following γ-radiation-induced DNA. Oncogene 26, 2365-2373.
9. Hanahan, D. and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
10. Hattori, M., Sakamoto, H., Satoh, K., and Yamamoto, T. (2001). DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett. 169, 155-164.
11. Kanai, M., Wei, D., Li, Q., Jia, Z., Ajani, J., Le, X., Yao, J., and Xie, K. (2006). Loss of Kruppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin. Cancer Res. 12, 6395-6402.
12. Li, F. and Altieri, D.C. (1999). Transcriptional analysis of human survivin gene expression. Biochem. J. 344, 305-311.
13. McConnell, B.B., Ghaleb, A.M., Nandan, M.O., and Yang, V.W. (2007). The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29, 549-557.
14. Mirza, A., McGuirk, M., Hockenberry, T.N., Wu, Q., Ashar, H., Black, S., Wen, S.F., Wang, L., Kirschmeier, P., Bishop, W.R., et al. (2002). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21, 2613-2622.
15. Ohnishi, S., Ohnami, S., Laub, F., Aoki, K., Suzuki, K., Kanai, Y., Haga, K., Asaka, M., Ramirez, F., and Yoshida, T. (2003). Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys. Res. Commun. 308, 251-256.
16. Rowland, B.D., Bernards, R., and Peeper, D.S. (2005). The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent Oncogene. Nat. Cell Biol. 7, 1074-1082.
17. Shie, J.L., Chen, Z.Y., Fu, M., Pestell, R.G., and Tseng, C.C. (2000). Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res. 28, 2969-2976.
18. Shields, J.M. and Yang, V.W. (1998). Identification of the DNA sequence that interacts with the gut-enriched Kruppel-like factor. Nucleic Acids Res. 26, 796-802.
19. Shields, J.M., Christy, R.J., and Yang, V.W. (1996). Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J. Biol. Chem. 271, 20009-20017.
20. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
21. Velculescu, V.E., Madden, S.L., Zhang, L., Lash, A.E., Yu, J., Rago, C., Lal, A., Wang, C.J., Beaudry, G.A., Ciriello, K.M., et al. (1999). Analysis of human transcriptomes. Nat. Genet. 23, 387-388.
22. Wang, Y., Zhu, H., Quan, L., Zhou, C., Bai, J., Zhang, G., Zhan, Q., and Xu, N. (2005a). Downregulation of survivin by RNAi inhibits the growth of esophageal carcinoma cells. Cancer Biol. Ther. 4, 974-978.
23. Wang, Y.H., Liu, S., Zhang, G., Zhou, C.Q., Zhu, H.X., Zhou, X.B., Quan, L.P., Bai, J.F., and Xu, N.Z. (2005b). Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res. 7, R220-R228.
24. Wei, D., Gong, W., Kanai, M., Schlunk, C., Wang, L., Yao, J.C., Wu, T.T., Huang, S., and Xie, K. (2005). Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res. 65, 2746-2754.
25. Xu, Y., Fang, F., Ludewig, G., Jones, G., and Jones, D. (2004). A mutation found in the promoter region of the human sur-vivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 23, 419-429.
26. Yasunaga, J., Taniguchi, Y., Nosaka, K., Yoshida, M., Satou, Y., Sakai, T., Mitsuya, H., and Matsuoka, M. (2004). Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res. 64, 6002-6009.
27. Yoon, H.S., Chen, X., and Yang, V.W. (2003). Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J. Biol. Chem. 278, 2101-2105.
28. Zhang, W., Shields, J.M., Sogawa, K., Fujii-Kuriyama, Y., and Yang, V.W. (1998). The gut-enriched Kruppel-like factor suppresses the activity of the CYP1A1 promoter in an Sp1-dependent fashion. J. Biol. Chem. 273, 17917-17925.
29. Zhang, W., Geiman, D.E., Shields, J.M., Dang, D.T., Mahatan, C.S., Kaestner, K.H., Biggs, J.R., Kraft, A.S., and Yang, V.W. (2000). The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J. Biol. Chem. 275, 18391-18398.
30. Zhu, H.X., Liu, S., Zhou, C.Q., Zhou, X.B., Zhang, F., Jin, L., and Xu, N.Z. (2002). Anti-apoptosis gene survivin promotes cell growth and transformation. Zhonghua Yi Xue Za Zhi 82, 338-340 (in Chinese).
31. Zhu, N., Gu, L., Findley, H.W., Chen, C., Dong, J.T., Yang, L., and Zhou, M. (2006). KLF5 interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia. J. Biol. Chem. 281, 14711-14718.